Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia

Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia

Bibliographic Details
Main Authors:	Michael L. Martini, Sean N. Neifert, J Mocco, Fedor Panov, Winona Tse, Ruth H. Walker, Jian Jin, Fiona Gupta
Format:	Article
Language:	English
Published:	Korean Movement Disorder Society 2019-09-01
Series:	Journal of Movement Disorders
Online Access:	http://www.e-jmd.org/upload/jmd-19029.pdf

Similar Items

Dysregulation of BET proteins in levodopa-induced dyskinesia
by: David A. Figge, et al.
Published: (2017-06-01)

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
by: Chang-Qing Zheng, et al.
Published: (2021-06-01)

Future Scenarios for Levodopa-induced Dyskinesias in Parkinson’s disease
by: Antonio eCerasa, et al.
Published: (2015-04-01)

Levodopa-induced belly dancer's dyskinesia: Case report
by: José Renan Miranda Cavalcante-Filho, et al.
Published: (2020-01-01)

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia
by: Mariangela Scarduzio, et al.
Published: (2022-05-01)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
by: Han Soo Yoo, et al.
Published: (2019-11-01)

Experimental study on the relationship between levodopa ⁃induced dyskinesia and phosphorylation of ERK in the striatum
by: Lu SONG, et al.
Published: (2011-02-01)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
by: Alejandro Martinez-Carrasco, et al.
Published: (2023-08-01)

Berberis vulgaris alleviates Levodopa-induced dyskinesia in male mice
by: Mokarian Faezeh, et al.
Published: (2018-12-01)

Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network
by: Asha eKishore, et al.
Published: (2014-08-01)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
by: Bargiotas P, et al.
Published: (2013-10-01)

Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
by: Paolo Calabresi, et al.
Published: (2019-12-01)

Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia
by: Pedro eBarroso Chinea, et al.
Published: (2010-09-01)

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
by: Heiman, Myriam, et al.
Published: (2014)

Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
by: Destany K. Kwon, et al.
Published: (2022-11-01)

SELECTIVE ACTIVATION OF STRIATAL INDIRECT PATHWAY SUPPRESSES LEVODOPA-INDUCED DYSKINESIAS
by: Ivan Castela, et al.
Published: (2023-10-01)

Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias
by: Iván Castela, et al.
Published: (2023-01-01)

Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease
by: Jinyoung Youn, et al.
Published: (2022-05-01)

The features of sensorimotor integration in patients with levodopa-induced dyskinesia in Parkinson’s disease
by: Olga A. Alenikova, et al.
Published: (2017-02-01)

Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
by: Michael H. Li, et al.
Published: (2018-11-01)

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease
by: Eva König, et al.
Published: (2021-10-01)

The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias
by: Vishakh Iyer, et al.
Published: (2021-11-01)

Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
by: Noriko Nishikawa, et al.
Published: (2022-09-01)

Pallidal versus subthalamic nucleus deep brain stimulation for levodopa‐induced dyskinesia
by: Shi‐Ying Fan, et al.
Published: (2020-01-01)

Current Knowledge on the Background, Pathophysiology and Treatment of Levodopa-Induced Dyskinesia—Literature Review
by: Michał Hutny, et al.
Published: (2021-09-01)

Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming
by: Takashi Nakamura, et al.
Published: (2023-06-01)

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
by: Bruno Lopes Santos-Lobato, et al.
Published: (2023-05-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
by: Changwei Yang, et al.
Published: (2020-03-01)

Potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model
by: Pegah Ashrafi, et al.
Published: (2022-11-01)

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats
by: Xuebing Cao, et al.

Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson’s Disease
by: Alfonsina Tirozzi, et al.
Published: (2021-04-01)

Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias
by: Jennifer Stanic, et al.
Published: (2017-12-01)

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence
by: Ritam Bandopadhyay, et al.
Published: (2022-04-01)

Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson’s Disease in the First 6 Years of Levodopa Treatment
by: Yang Luo, et al.
Published: (2023-07-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
by: Song L,Yuan W, et al.
Published: (2012-11-01)

Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson’s disease
by: Jeongrak Park, et al.
Published: (2024-01-01)

Slow wave activity across sleep-night could predict levodopa-induced dyskinesia
by: Ninfa Amato, et al.
Published: (2023-09-01)

Investigation of <i>PRKN</i> Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
by: Ana Gabrielle Bispo, et al.
Published: (2023-08-01)